The 2026 World Cup was meant to be a crowning achievement for the Argentine Football Association (AFA), a moment of global triumph on the biggest stage imaginable. Instead, under the leadership of President Claudio Tapia, the federation has found itself trapped in a chaotic, multi-front war that feels more like a political thriller than a sporting event. While the players have been busy navigating the pressures of the knockout rounds, the administrative arm of the AFA is currently struggling to keep its head above water. Between federal investigations and a digital landscape poisoned by disinformation, the AFA is facing a…

The weight-loss pharmaceutical landscape has officially turned into a high-stakes legal battleground. Novo Nordisk, the powerhouse behind the household names Ozempic and Wegovy, recently launched a significant lawsuit against its primary rival, Eli Lilly. At the heart of the dispute is Eli Lilly’s marketing strategy for Zepbound, a competing weight-loss medication. Novo Nordisk contends that these advertisements are not merely aggressive, but fundamentally deceptive, misleading the public by painting an inaccurate picture of how the two drugs compare in efficacy. The core of Novo Nordisk’s grievance lies in how the data was presented. They argue that Eli Lilly’s promotional materials…